CG Oncology, Inc.
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 56.33% | 0.02% | 25.81% | 19.57% | 21.52% |
| Total Receivables | 269.57% | -- | 275.91% | 208.79% | 125.49% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 86.36% | 23.38% | 20.28% | 5.68% | 3.88% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 57.18% | 0.70% | 26.03% | 19.36% | 21.19% |
|
|
|||||
| Total Current Assets | 57.18% | 0.70% | 26.03% | 19.36% | 21.19% |
| Net Property, Plant & Equipment | 1,410.10% | 3,868.97% | 5,678.70% | 194.92% | 191.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -89.58% | 1,685.11% | 115.09% | 51,215.09% | 48,375.47% |
| Total Assets | 55.90% | 4.87% | 32.12% | 24.30% | 25.74% |
|
|
|||||
| Total Accounts Payable | 22.36% | -12.32% | 125.54% | 58.65% | 44.50% |
| Total Accrued Expenses | 57.86% | 62.48% | 76.63% | 224.95% | 214.57% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 318.04% | 391.94% | 305.33% | 21.52% | 15.91% |
| Total Finance Division Other Current Liabilities | 307.28% | 149.54% | 263.35% | 83.97% | 70.57% |
| Total Other Current Liabilities | 307.28% | 149.54% | 263.35% | 83.97% | 70.57% |
| Total Current Liabilities | 55.53% | 44.31% | 95.32% | 156.31% | 126.78% |
|
|
|||||
| Total Current Liabilities | 55.53% | 44.31% | 95.32% | 156.31% | 126.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 349.30% | 5,873.08% | 4,588.73% | 498.31% | 324.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 85.64% | 82.03% | 169.22% | 159.69% | 130.36% |
|
|
|||||
| Common Stock & APIC | 59.94% | 18.94% | 41.82% | 34.27% | 33.72% |
| Retained Earnings | -73.98% | -73.86% | -81.36% | -77.26% | -71.87% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 54.92% | 2.62% | 28.11% | 21.36% | 23.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 54.92% | 2.62% | 28.11% | 21.36% | 23.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 54.92% | 2.62% | 28.11% | 21.36% | 23.87% |
|
|
|||||